TAO Synergies Inc. Files 8-K
Ticker: TAOX · Form: 8-K · Filed: Jul 17, 2025 · CIK: 1571934
| Field | Detail |
|---|---|
| Company | Tao Synergies Inc. (TAOX) |
| Form Type | 8-K |
| Filed Date | Jul 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-event, filing, financial-reporting
TL;DR
TAO Synergies (TAOS) filed an 8-K on 7/17/25. Nothing major, just corporate housekeeping.
AI Summary
TAO Synergies Inc. filed an 8-K on July 17, 2025, reporting on other events and financial statements. The company, formerly known as Synaptogenix, Inc. and Neurotrope Bioscience, Inc., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing provides an update on the company's corporate activities and financial reporting, which is important for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for corporate events and financial statements, not indicating any immediate operational or financial distress.
Key Players & Entities
- TAO Synergies Inc. (company) — Registrant
- July 17, 2025 (date) — Date of earliest event reported
- Synaptogenix, Inc. (company) — Former company name
- Neurotrope Bioscience, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- 2834 (industry_code) — Standard Industrial Classification
- 1185 Avenue of the Americas, 3rd Floor (address) — Principal executive offices
- New York, New York 10036 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing by TAO Synergies Inc.?
The filing is a Current Report on Form 8-K, reporting on Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits, with the earliest event reported on July 17, 2025.
What were TAO Synergies Inc.'s previous names?
TAO Synergies Inc. was formerly known as Synaptogenix, Inc. (name change effective 20201210) and prior to that, NEUROTROPE BIOSCIENCE, INC. (name change effective 20130312).
In which state is TAO Synergies Inc. incorporated and what is its SIC code?
TAO Synergies Inc. is incorporated in Delaware and its Standard Industrial Classification code is 2834 (Pharmaceutical Preparations).
What is the principal executive office address for TAO Synergies Inc.?
The principal executive office address is 1185 Avenue of the Americas, 3rd Floor, New York, New York 10036.
What is the filing date for this 8-K report?
The filing date for this 8-K report is July 17, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 17, 2025 regarding TAO Synergies Inc. (TAOX).